Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura

American Journal of Hematology

Volumn 90, Issue 8, 2015, Pages 709-714

  Han, Bowie ^a   Page, Evaren E ^a   Stewart, Lauren M ^a   Deford, Cassandra C ^a   Scott, James G ^a   Schwartz, Lauren H ^a   Perdue, Jedidiah J ^a   Terrell, Deirdra R ^a   Vesely, Sara K ^a   George, James N ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN;

ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONVALESCENCE; DEPRESSION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MONTREAL COGNITIVE ASSESSMENT; PRIORITY JOURNAL; REPEATABLE BATTERY FOR ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; ADULT; AGED; COGNITION DISORDERS; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION; GENETICS; INTELLIGENCE TEST; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PLASMA EXCHANGE; PSYCHOLOGY; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REGISTER; SEVERITY OF ILLNESS INDEX;

ADAM PROTEINS; ADULT; AGED; COGNITION DISORDERS; CONVALESCENCE; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION; HUMANS; INTELLIGENCE TESTS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; REGISTRIES; SEVERITY OF ILLNESS INDEX;

EID: 84937525776     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24060     Document Type: Article

References (31)

1. Reese JA, Muthurajah DS, Kremer Hovinga JA, et al. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired adamts13 deficiency: Comparison of incidence, demographic and clinical features. Pediatr Blood Cancer 2013;60:1676-1682.
2. Howard MA, Duvall D, Terrell DR, et al. A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: The six year experience of the Oklahoma TTP-HUS study group. J Clin Apheresis 2003;18:16-20.
3. Ambadwar P, Duvall D, Wolf NJ, et al.. Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apheresis 2008;23:168-169.
4. Lewis QF, Lanneau MS, Mathias SD, et al.. Long-term deficits in health-related quality of life following recovery from thrombotic thrombocytopenic purpura. Transfusion 2009;49:118-124.
5. Kennedy KA, Lewis QF, Scott JG, et al. Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion 2009;49:1092-1101.
6. Deford CC, Reese JA, Schwartz LH, et al. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood 2013;122:2023-2029.
7. Vesely SK, George JN, Lämmle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003;101:60-68.
8. Kremer Hovinga JA, Vesely SK, Terrell DR, et al. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2010;115:1500-1511.
9. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of beck depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996;67:588-597.
10. Arnau RC, Meagher MW, Norris MP, Bramson R. Psychometric evaluation of the beck depression Inventory-II with primary care medical patients. Health Psychol 2015;2001:20-112.
11. Gelenberg AJ, Freeman MP, Markowitz JC, et al. Practice guideline for the treatment of patients with major depressive disorder. xxx [2010 (3) Available from: URL:http://psychiatryonline.org/pb/assets/raw/sitewide/practice:guidelines/guidelines/mdd.pdf.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DMS IV-TR), 4th (revised) ed. American Psychiatric Association; Arlington, VA; 2000.
13. Sullivan GM, Feinn R. Using effect size-Or why the P value is not enough. J Grad Med Educ 2012;4:279-282.
14. U.S. Preventive Services Taskforce. Screening for depression in adults: U.S. preventive services taskforce recommendation statement. Ann Intern Med 2009;151:784-792.
15. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Int Med 1997;12:439-445.
16. Terrell DR, Stewart LM, Tolma EL, et al. Thrombotic thormbocytopenic purpura (TTP) patient attitudes regarding depression management: A qualitative study (abstract). Blood 2014;124:203.
17. Cuijpers P, Beekman ATF, Renolds CFI. Preventing depression. A global priority. J Am Med Assoc 2012;307:1033-1034.
18. Cuijpers P, Smit F. Excess mortality in depression: A meta-analysis of community studies. J Affect Disord 2002;72:227-236.
19. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
20. van Exel E, Jacobs J, Korswagen LA, et al. Depression in systemic lupus erythematosus, dependent on or independent of severity of disease. Lupus 2013;22:1462-1469.
21. George JN, Vesely SK, James JA. Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. Southern Med J 2007;100:512-514.
22. Gonzalez O, Berry JT, McKnight-Eily LR, et al. Current depression among adults-United States, 2006 and 2008. MMWR 2010;59:1229-1235.
23. Luppino FS, de Wilt LM, Bouvy PF, et al. Overweight, obesity, and depression. A systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010;67:220-229.
24. Kauhanen ML, Korpelainen JT, Hiltunin P, et al. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 1999;30:1875-1880.
25. Vermeer SE, Prins MD, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. New Engl J Med 2003;348:1215-1222.
26. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-2041.
27. Little DJ, Reese JA, Vesely SK, George JN. Increased urinary albumin excretion following recovery from acquired thrombotic thrombocytopenic purpura. Am J Kidney Dis 2014;64:317-318.
28. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005;76:469-475.
29. Jackson JC, Mitchell N, Hopkins RO. Cognitive functioning, mental health, and quality of life in ICU survivors: An overview. Anesthesiology 2011;29:751-764.
30. Ayerbe L, Ayis S, Crichton S, et al. The natural history of depression up to 15 years after stroke: The South London stroke register. Stroke 2013;44:1105-1110.
31. Hellmann-Regen J, Piber D, Hinkelmann K, et al. Depressive syndromes in neurological disorders. Eur Arch Psychiatry Clin Neurosci 2013;263: S123-S136.